Transforming care
with Ultrasound Data

To impact millions of lives worldwide

Save lives by providing a diagnosis
at the right time

The digital revolution in ultrasound unlocks more accurate diagnoses and faster patient care.
We’re just scratching the surface to understand the impact of our developments.

01

First Responders

Enable pre-hospital triage for stroke and other critical conditions. Improve patient outcomes with faster, life-saving decisions.

Check eligibility for life-saving therapies to streamline patient triage before reaching the hospital.

02

Emergencies

Allow a better patient stratification to prioritize hospital resource allocation when access to imaging is limited.

03

Image studies

Provide numerical and precise insights into tissue morphology and function to aid in quantifying disease severity and tracking progression.

04

Interventions

Facilitate both the preparation and monitoring of invasive procedures to help anticipate and reduce complications.

05

Critical care

Bring imaging at the point of care, eliminate the need to transport critically ill patients to radiology, and reduce the time required to coordinate clinical schedules and support staff

Enhance point-of-care decision-making by providing additional data to mitigate the risk of potential deadly complications

06

Control

Establish a sustainable approach for follow-up and screening, addressing long-term effects and rehabilitation needs including for neurodegenerative diseases.

Lead the next leap
in non-molecular diagnostics

01

MRI & CT scans are at the forefront of the digital transition

Benefiting from well-structured databases and reduced systemic biases such as operator dependencies. However, their availability for many patients remains limited by high hardware and infrastructure costs. Restricted access and data constraints hinder potential breakthroughs.

02

Ultrasound is a widely accessible imaging technology

However, conventional ultrasound remains limited due to performance constraints, with only 10% of the raw data being utilized, and it remains an operator-dependent imaging modality.

Empowering medical decisions
with Ultrasound

OUR AMBITION

Build Ultrasound software engine
To widen the access to diagnostics, solve unmet medical needs and support tomorrow ‘s precision treatments.

OUR FIRST APPLICATION

Make Ultrasound relevant for Brain Imaging
with transcranial imaging of the cerebral blood flows for neurology, intensive care and emergency medicine

The first application of our engine will be made available in SYLVER*,
an autonomous Ultrasound scanner designed for critical care.

*In development, not available for sale.

01

Accessible

Non-invasive, safe, compact, and user-friendly, no advanced expertise needed.

02

Reliable quantitative insights

Access to new markers for monitoring the cerebral blood flow and perfusion.

Bring change
to all stakeholders

Advance toward a more personalized treatment for critically ill patients.
Drive growth & improve productivity of neurocritical care departments.
Participate in overall cost reduction with strong medico-economic benefits.

From imaging
to predictive insights

Lead the digital transition in Ultrasound imaging

Harness the power of software-driven Ultrasound to improve imaging performances, reduce operator dependency and validate quantitative imaging biomarkers.

Provide a clinical data acquisition platform to empower ambitious clinical research projects and biomarker development.

Reveal the full potential of data-driven Ultrasound

Build a comprehensive database with raw Ultrasound data and clinical labels to engage in the AI revolution.

Leverage the clinical value of data-driven biomarkers to accelerate drug development for pharmaceutical companies.

Creating change together

Supported by partners

Collaborating with Industry leaders, Hospitals, and Healthcare associations to drive innovation and excellence in ultrasound diagnostics.

Supported by investors

Empowered by our investors to lead the next leap in non-molecular diagnostics.

Supported by awards

Recognized for our excellence and innovation with prestigious awards.

Our latest news

News

Prix Galien 2025 Official Selection

France, Prix Galien 2025, July 2025

Resolve Stroke is honored to be officially selected for the 2025 Prix Galien France in the Medtech & Digital Solutions category. This prestigious nomination highlights the impact and potential of our ultrasound-based neuroimaging technology to advance patient care. We thank the Prix Galien jury for recognizing our commitment to innovation in healthcare.

Events

Resolve Stroke hosts neuro-ultrasound workshop at Station F

France, Station F, June 2025

Resolve Stroke organized a hands-on workshop at Station F, bringing together clinicians and researchers interested in the future of ultrasound in neurocritical care. Participants discovered our SYLVER platform and RS Suite, joined expert-led discussions, and explored how software-driven ultrasound can unlock new possibilities for brain monitoring at the bedside. Thank you to all who joined!

Events

VivaTech 2025

France, VivaTech 2025, June 2025

Resolve Stroke was invited to pitch on stage at VivaTech 2025 in Paris, thanks to the support of CNRS. We were thrilled to present our innovations in health tech and to connect with industry leaders at this major international event.

News

2.5M€ EIC Transition Grant Award

European Innovation Council, June 2025

We are proud to announce that the RS-NeuroMarkers project has been selected by the European Innovation Council for a prestigious EIC Transition Grant. This €2.5M grant recognizes our mission to advance point-of-care neuroimaging, making brain monitoring more accessible through ultrasound technology. With RS-NeuroMarkers, we will integrate clinically validated brain biomarkers into our software engine, helping clinicians detect and monitor cerebral pathologies directly at the bedside.

Events

Resolve Stroke Pitch at NYC Deep Tech Week

New York City, Deep Tech Week, April 2025

Our CTO Vincent Hingot took the stage at Deep Tech Week in New York City to present Resolve Stroke’s vision for the future of neuroimaging. Vincent shared how we leverage ultrasound physics and advanced signal processing to deliver real-time brain insights. We’re honored to be part of this vibrant community of innovators shaping the future of medicine.

Press

Bedside brain perfusion imaging: Dr. Gakuba showcases SYLVER platform

Le Quotidien du Médecin, March 2025

In a recent video interview published by Le Quotidien du Médecin, Dr. Clément Gakuba (CHU Caen) highlights how our SYLVER ultrasound device enables advanced brain perfusion imaging directly at the patient’s bedside. The technology was evaluated in a first clinical study involving 15 patients with subarachnoid hemorrhage, demonstrating both feasibility and the ability to identify different perfusion profiles.

News

Clinical trial – First results

France, French Society of Anaesthesia and Intensive Care, Sept. 2024

First results from the collaboration between CHU Caen Normandie and Resolve Stroke officially presented at the SFAR meeting (French Society of Anaesthesia and Intensive Care), sparking great interest within the community.

Events

JFR 2024

France, Journées Francophones de Radiologie, Oct. 2024

One year after winning the Innovation in Medical Imaging Award at JFR 2023, we were thrilled to present the latest advancements and developments from Resolve Stroke, along with our clinical results.  It’s a great honor to have our work recognized by industry leaders.

News

First Patients enrolled in clinical trial using Resolve Stroke’s SYLVER Platform

LinkedIn, July 2024

Resolve Stroke has enrolled the first patients in a groundbreaking clinical trial using its #SYLVER platform to evaluate transcranial ultrasound data for detecting cerebral hypoperfusion in neurocritical care units. This significant milestone brings us closer to revolutionizing the application of ultrasound in neurology, much like the transformative journey of cardiac ultrasound years ago.

Events

NVIDIA event X Resolve Stroke

Belgium, NVIDIA event, Sept. 2024

Our Lead Software Developer Maxence Reberol has been invited by NVIDIA to participate to an incredible event in Belgium 🇧🇪 at the Orsi Academy to push the boundaries of cutting-edge healthcare computing applications.